Exosomes from senescent cells could revolutionize cancer therapy delivery
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
20 articles
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
Surface proteins on tiny cellular packages could revolutionize early breast cancer detection through simple blood tests.
Scientists explore how exosomes in urine samples could revolutionize early cancer detection through simple, non-invasive testing.
Activated T cells release vesicles carrying genomic DNA that reprogram recipient cells to display tumor antigens more effectively.
A novel immune-evasion mechanism in triple-negative breast cancer reveals how cancer stem cells suppress anti-tumor immunity via extracellular vesicles.
Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.
Novel nanoparticle combines protein degrader with light therapy to reprogram cancer metabolism and eliminate breast tumors.
Researchers discover why combining chemotherapy with immunotherapy works better and identify a key resistance mechanism.
Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.
Synthetic super-enhancers hijack glioblastoma's own regulatory circuits to trigger precise, tumor-only cell death and durable immune memory.
Scientists discover how to reprogram cancer cells into harmless, non-dividing cells by targeting a nuclear enzyme pathway.
Researchers found that stopping HER2 protein degradation significantly improves trastuzumab deruxtecan cancer treatment outcomes.
Novel treatment triggers ferroptosis in cancer cells while activating immune responses that further enhance cancer cell death.
Researchers discover how cancer cells use lysosomes to resist RNA polymerase inhibitors and develop combination strategies to overcome this resistance.
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.
New research reveals how blocking specific enzymes could dramatically improve cancer immunotherapy effectiveness by removing immune suppression.
Scientists develop safer way to deliver immune-boosting genes directly to tumors, enhancing radiation therapy effectiveness.
Scientists identify a mitochondria-proteasome-haem pathway that silences immune cells โ and show bortezomib can fix it in CAR-T therapy.
Researchers use advanced cell profiling to develop personalized immune treatments for thyroid cancer patients.